New research has identified depression and gastrointestinal disorders as early warning signs of progressive supranuclear palsy (PSP), a rare neurodegenerative condition. The study, which analyzed UK Biobank data, found that these symptoms can appear years before a PSP diagnosis, providing clinicians with a crucial window for earlier intervention.
The study involved a matched nested case-control analysis of over 500,000 adults aged 37 to 73, identifying 240 cases of PSP. Depression was strongly linked to PSP, with an odds ratio of 3.22 (95% CI 2.30 to 4.50, P < 0.001). Delirium and functional gastrointestinal disorders also significantly increased the risk, with odds ratios of 6.76 (95% CI 4.08 to 11.19, P < 0.001) and 1.91 (95% CI 1.39 to 2.63, P < 0.001), respectively.
Clinicians should consider earlier neurological evaluations in patients presenting with persistent depression, delirium, or functional bowel disorders, especially when accompanied by atypical motor complaints. The study also noted an inverse association with cancer, suggesting shared biological mechanisms that warrant further exploration.
Future research will focus on understanding the mechanistic pathways and developing risk stratification tools to improve early detection and personalized management of PSP.